Spero Therapeutics, Inc.
SPRO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001701108
No open-market purchases or sales by Spero Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $47.5M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Spero Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 50 | 54 | +4 |
| Shares | 13.8M | 13.8M | −77.9K (−0.6%) |
| Value | $19.6M | $23.7M | +$4.02M (+20.4%) |
New holders (11)
Institutions that held Spero Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Shay Capital LLC | 306,967 | $528.0K | 0.15% |
| Man Group plc | 214,026 | $368.1K | 0.00% |
| Bank of Montreal | 79,500 | $139.9K | 0.00% |
| Bailard, Inc. | 60,900 | $104.7K | 0.00% |
| Gsa Capital Partners LLP | 28,319 | $49.0K | 0.00% |
| Virtu Financial LLC | 18,180 | $31.0K | 0.00% |
| WR Wealth Planners, LLC | 2,600 | $4.47K | 0.00% |
| Lazard Asset Management LLC | 1,248 | $2.00K | 0.00% |
| IFP Advisors, Inc | 650 | $1.12K | 0.00% |
| Raleigh Capital Management Inc. | 500 | $860 | 0.00% |
| CoreCap Advisors, LLC | 142 | $244 | 0.00% |
Sold out (7)
Institutions that held Spero Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Ameriprise Financial Inc | 402,963 | $592.4K |
| Citadel Advisors LLC | 32,274 | $47.4K |
| Susquehanna International Group, LLP | 18,086 | $26.6K |
| Bourgeon Capital Management LLC | 15,100 | $22.2K |
| Two Sigma Securities, LLC | 10,301 | $15.1K |
| Group One Trading, L.P. | 4,590 | $6.75K |
| Royal Bank of Canada | 315 | $0 |